Literature DB >> 15282748

Thyrocyte-specific expression of Cre recombinase in transgenic mice.

Takashi Kusakabe1, Akio Kawaguchi, Rumi Kawaguchi, Lionel Feigenbaum, Shioko Kimura.   

Abstract

A transgenic mouse line that expresses Cre recombinase under control of the human thyroid peroxidase (TPO) gene promoter was established. The activity and specificity of the TPO-driven Cre recombinase were examined by using Northern blotting and by crossing with the ROSA26 reporter transgenic mouse line. In the latter mice, Cre-mediated recombination occurred only in the thyrocytes, and recombination commenced around embryonic day 14.5, at the time during thyroid organogenesis when TPO expression begins. This study demonstrates that the TPO-Cre transgenic mouse is a powerful tool to specifically delete loxP-inserted (floxed) genes in thyrocytes and will be of great value in the study of thyrocyte-specific genes during development and/or in adult thyroids. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282748     DOI: 10.1002/gene.20043

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  45 in total

1.  Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.

Authors:  Saverio Bellusci; Parviz Minoo; Caterina Tiozzo; Soula Danopoulos; Maria Lavarreda-Pearce; Sheryl Baptista; Radka Varimezova; Denise Al Alam; David Warburton; Rehan Virender; Stijn De Langhe; Antonio Di Cristofano
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

2.  Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse.

Authors:  Roch-Philippe Charles; Gioia Iezza; Elena Amendola; David Dankort; Martin McMahon
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

3.  Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.

Authors:  Melissa E Dobson; Ericka Diallo-Krou; Vladimir Grachtchouk; Jingcheng Yu; Lesley A Colby; John E Wilkinson; Thomas J Giordano; Ronald J Koenig
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

4.  Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy.

Authors:  Tapan K Bera; Wenlong Liu; Jasmin Leshem; Emily King; Serguei Kozlov; Ira Pastan
Journal:  J Immunother       Date:  2019-05       Impact factor: 4.456

5.  Identification of the Genomic Insertion Site of the Thyroid Peroxidase Promoter-Cre Recombinase Transgene Using a Novel, Efficient, Next-Generation DNA Sequencing Method.

Authors:  Priyadarshini Raman; Vladimir Grachtchouk; Robert H Lyons; Ronald J Koenig
Journal:  Thyroid       Date:  2015-08-07       Impact factor: 6.568

6.  Elevated HMGN4 expression potentiates thyroid tumorigenesis.

Authors:  Jamie Kugler; Yuri V Postnikov; Takashi Furusawa; Shioko Kimura; Michael Bustin
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

7.  NADPH Oxidase NOX4 Is a Critical Mediator of BRAFV600E-Induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas.

Authors:  Naïma Azouzi; Jérémy Cailloux; Juliana M Cazarin; Jeffrey A Knauf; Jennifer Cracchiolo; Abir Al Ghuzlan; Dana Hartl; Michel Polak; Aurore Carré; Mohammed El Mzibri; Abdelkarim Filali-Maltouf; Abderrahmane Al Bouzidi; Martin Schlumberger; James A Fagin; Rabii Ameziane-El-Hassani; Corinne Dupuy
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

8.  Thyroid-Specific PPARγ Deletion Is Benign in the Mouse.

Authors:  Jingcheng Yu; Ronald J Koenig
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

Review 9.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

10.  Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.

Authors:  Kelly A Miller; Nicole Yeager; Kristen Baker; Xiao-Hui Liao; Samuel Refetoff; Antonio Di Cristofano
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.